United Therapeutics Corp (UTHR)
274.29
+2.07
(+0.76%)
USD |
NASDAQ |
May 17, 16:00
274.29
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Gross Profit (TTM): 2.220B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 2.220B |
December 31, 2023 | 2.07B |
September 30, 2023 | 1.959B |
June 30, 2023 | 1.898B |
March 31, 2023 | 1.803B |
December 31, 2022 | 1.785B |
September 30, 2022 | 1.733B |
June 30, 2022 | 1.671B |
March 31, 2022 | 1.643B |
December 31, 2021 | 1.563B |
September 30, 2021 | 1.532B |
June 30, 2021 | 1.472B |
March 31, 2021 | 1.398B |
December 31, 2020 | 1.375B |
September 30, 2020 | 1.307B |
June 30, 2020 | 1.320B |
March 31, 2020 | 1.331B |
December 31, 2019 | 1.331B |
September 30, 2019 | 1.398B |
June 30, 2019 | 1.391B |
March 31, 2019 | 1.427B |
December 31, 2018 | 1.429B |
September 30, 2018 | 1.491B |
June 30, 2018 | 1.556B |
March 31, 2018 | 1.599B |
Date | Value |
---|---|
December 31, 2017 | 1.620B |
September 30, 2017 | 1.588B |
June 30, 2017 | 1.547B |
March 31, 2017 | 1.514B |
December 31, 2016 | 1.526B |
September 30, 2016 | 1.525B |
June 30, 2016 | 1.520B |
March 31, 2016 | 1.458B |
December 31, 2015 | 1.397B |
September 30, 2015 | 1.348B |
June 30, 2015 | 1.258B |
March 31, 2015 | 1.210B |
December 31, 2014 | 1.163B |
September 30, 2014 | 1.082B |
June 30, 2014 | 1.065B |
March 31, 2014 | 1.029B |
December 31, 2013 | 985.86M |
September 30, 2013 | 941.77M |
June 30, 2013 | 884.76M |
March 31, 2013 | 832.42M |
December 31, 2012 | 796.78M |
September 30, 2012 | 760.48M |
June 30, 2012 | 725.04M |
March 31, 2012 | 691.69M |
December 31, 2011 | 654.28M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.307B
Minimum
Sep 2020
2.220B
Maximum
Mar 2024
1.610B
Average
1.548B
Median
Gross Profit (TTM) Benchmarks
Liquidia Corp | 12.27M |
Ligand Pharmaceuticals Inc | 108.64M |
Esperion Therapeutics Inc | 188.05M |
Vertex Pharmaceuticals Inc | 8.847B |
ANI Pharmaceuticals Inc | 324.50M |